The Latest Breaking News from Biogen

Science.org reported Sunday that a woman participating in the joint Biogen-Eisai Clarity AD trial of an experimental Alzheimer's treatment has died of a brain hemorrhage.

Hemgenix frees patients from repeated treatments but initial cost makes it most expensive medicine in the world

After years of setbacks, dementia researchers are getting excited about a new antibody drug called lecanemab. No one expects it to stop cognitive decline, but even slowing it would be a breakthrough

Despite signs of inflation cooling in the United States, the IMF is not expecting the global economic picture to improve anytime soon. However, the cooling inflation might induce the Fed to ease the pace of rate hikes. As economic uncertainties remain, we think fundamentally solid stocks McDonald’s (MCD) and Biogen…